Detalles de la búsqueda
1.
Risk factor analysis for a rapid progression of chronic kidney disease.
Nephrol Dial Transplant;
2024 Jan 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38168720
2.
Albuminuria-lowering effect of adding semaglutide on top of empagliflozin in individuals with type 2 diabetes: A randomized and placebo-controlled study.
Diabetes Obes Metab;
26(1): 54-64, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37722966
3.
The development of type 2 diabetes management in people with severe mental illness in the Capital Region of Denmark from 2001 to 2015.
Acta Psychiatr Scand;
149(3): 219-233, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38183340
4.
"I Haven't Told Anyone but You": Experiences and Biopsychosocial Support Needs of People With Type 2 Diabetes and Binge Eating.
Qual Health Res;
34(7): 621-634, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38183221
5.
Clinical implications and guidelines for CKD in type 2 diabetes.
Nephrol Dial Transplant;
38(3): 542-550, 2023 02 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-36264310
6.
Sotagliflozin, a dual sodium-glucose co-transporter-1 and sodium-glucose co-transporter-2 inhibitor, reduces the risk of cardiovascular and kidney disease, as assessed by the Steno T1 Risk Engine in adults with type 1 diabetes.
Diabetes Obes Metab;
25(7): 1874-1882, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36872068
7.
Overall and inter-individual effect of four different drug classes on soluble urokinase plasminogen activator receptor in type 1 and type 2 diabetes.
Diabetes Obes Metab;
25(11): 3152-3160, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37417375
8.
Initiation of glucose-lowering drugs reduces the anticoagulant effect of warfarin-But not through altered drug metabolism in patients with type 2 diabetes.
Br J Clin Pharmacol;
89(8): 2529-2541, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36967527
9.
The effect of metformin treatment on volumes of free-living physical activity and sedentary behaviour: A post-hoc analysis of the PRE-D trial.
J Sports Sci;
41(18): 1687-1691, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-38053246
10.
Time trends of cardiovascular risk management in type 1 diabetes - nationwide analyses of real-life data.
Cardiovasc Diabetol;
21(1): 255, 2022 11 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-36419118
11.
Flexible inclusion of dialogue about psychosocial aspects of life with type 1 diabetes in routine consultations: A study of a questionnaire-based dialogue tool to promote person-centred support.
Diabet Med;
39(8): e14881, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35560258
12.
Impact of random variation in albuminuria and estimated glomerular filtration rate on patient enrolment and duration of clinical trials in nephrology.
Diabetes Obes Metab;
24(6): 983-990, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35112455
13.
The importance of addressing multiple risk markers in type 2 diabetes: Results from the LEADER and SUSTAIN 6 trials.
Diabetes Obes Metab;
24(2): 281-288, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34676658
14.
The effects of dapagliflozin, metformin or exercise on glycaemic variability in overweight or obese individuals with prediabetes (the PRE-D Trial): a multi-arm, randomised, controlled trial.
Diabetologia;
64(1): 42-55, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33064182
15.
Visit-to-visit variability of clinical risk markers in relation to long-term complications in type 1 diabetes.
Diabet Med;
38(5): e14459, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33179275
16.
Copeptin and renal function decline, cardiovascular events and mortality in type 1 diabetes.
Nephrol Dial Transplant;
37(1): 100-107, 2021 12 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-33367877
17.
A large remaining potential in lipid-lowering drug treatment in the type 2 diabetes population: A Danish nationwide cohort study.
Diabetes Obes Metab;
23(10): 2354-2363, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34189831
18.
No effects of dapagliflozin, metformin or exercise on plasma glucagon concentrations in individuals with prediabetes: A post hoc analysis from the randomized controlled PRE-D trial.
Diabetes Obes Metab;
23(2): 530-539, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33146457
19.
Drug-drug interaction between warfarin and statins: A Danish cohort study.
Br J Clin Pharmacol;
87(2): 694-699, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32533893
20.
Mitigating risk of aldosterone in diabetic kidney disease.
Curr Opin Nephrol Hypertens;
29(1): 145-151, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31599747